Intake of marine-derived omega-3 polyunsaturated fatty acids and mortality in renal transplant recipients

Autor: Ilse G. Pranger, Camilo G. Sotomayor, Sabita S. Soedamah-Muthu, Stephan J. L. Bakker, Rijk O. B. Gans, Else van den Berg, Antonio W. Gomes Neto, Gerjan Navis
Přispěvatelé: Lifestyle Medicine (LM), Groningen Kidney Center (GKC), Groningen Institute for Organ Transplantation (GIOT), Value, Affordability and Sustainability (VALUE), Lifelong Learning, Education & Assessment Research Network (LEARN), Medical and Clinical Psychology
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
medicine.medical_specialty
Cardiovascular mortality
Nutrition and Disease
renal transplant recipients
omega-3 polyunsaturated fatty acids
cardiovascular mortality
all-cause mortality
lcsh:TX341-641
030204 cardiovascular system & hematology
Lower risk
Gastroenterology
Renal transplant recipients
03 medical and health sciences
0302 clinical medicine
QUALITY-OF-LIFE
Internal medicine
Voeding en Ziekte
medicine
CORONARY-HEART-DISEASE
Prospective cohort study
FISH-OIL
VLAG
chemistry.chemical_classification
RISK
Nutrition and Dietetics
business.industry
Proportional hazards model
Omega-3 polyunsaturated fatty acids
Hazard ratio
All-cause mortality
Eicosapentaenoic acid
Confidence interval
C-REACTIVE PROTEIN
Surgery
030104 developmental biology
chemistry
Docosahexaenoic acid
OXIDATIVE DAMAGE
SURVIVAL
lipids (amino acids
peptides
and proteins)

DIETARY SUPPLEMENTATION
business
lcsh:Nutrition. Foods and food supply
Food Science
Polyunsaturated fatty acid
SMOKERS
OMEGA-3-FATTY-ACIDS
Zdroj: Nutrients, 9(4)
Nutrients 9 (2017) 4
Nutrients, Vol 9, Iss 4, p 363 (2017)
Nutrients; Volume 9; Issue 4; Pages: 363
Nutrients, 9(4):363. MDPI AG
Nutrients, 9(4):363. Multidisciplinary Digital Publishing Institute (MDPI)
ISSN: 2072-6643
Popis: The effect of marine-derived omega-3 polyunsaturated fatty acids (n-3 PUFA) on long-term outcome in renal transplant recipients (RTR) remains unclear. We investigated whether marine-derived n-3 PUFA intake is associated with all-cause and cardiovascular (CV) mortality in RTR. Intake of eicosapentaenoic acid plus docosahexaenoic acid (EPA-DHA) was assessed using a validated Food Frequency Questionnaire. Cox regression analyses were performed to evaluate the associations of EPA-DHA intake with all-cause and CV mortality. We included 627 RTR (age 53 +/- 13 years). EPA-DHA intake was 102 (42-215) mg/day. During median follow-up of 5.4 years, 130 (21%) RTR died, with 52 (8.3%) due to CV causes. EPA-DHA intake was associated with lower risk of all-cause mortality (Hazard Ratio (HR) 0.85; 95% confidence interval (95% CI) 0.75-0.97). Age (p = 0.03) and smoking status (p = 0.01) significantly modified this association, with lower risk of all-cause and CV mortality particularly in older (HR 0.75, 95% CI 0.61-0.92; HR 0.68, 95% CI 0.48-0.95) and non-smoking RTR (HR 0.80, 95% CI 0.68-0.93; HR 0.74, 95% CI 0.56-0.98). In conclusion, marine-derived n-3 PUFA intake is inversely associated with risk of all-cause and CV mortality in RTR. The strongest associations were present in subgroups of patients, which adds further evidence to the plea for EPA-DHA supplementation, particularly in elderly and non-smoking RTR.
Databáze: OpenAIRE